Study of COV795 in Subjects With Osteoarthritis or Chronic Low Back Pain

Summary

The primary objective is to demonstrate the safety and tolerability of COV795 with up to 35 days use as evaluated by physical exam, vital signs, pulse oximetry, clinical laboratory tests, and other adverse events (AEs).

Timeline

Start

2011-09-20

Primary completion

2012-06-18

Completion

2012-06-18

Drugs

Indications